Arcus Biosciences to Discuss the Expanded Partnership with Gilead Sciences Inc- Conference Call Transcript
Hello all. I would like to welcome you to the Arcus Biosciences Corporate Update Call. My name is Brika, and I'll be today's event specialist. (Operator Instructions)
I would now like to hand the call over to your host, Holli. So Holli, please go ahead.
Good morning, everyone. Thank you, Brika. Thank you all for participating in today's call to discuss our announcement this morning regarding Gilead's early option exercises. Joining me from Arcus are Terry Rosen, Chief Executive Officer; Juan Jaen, President; Jennifer Jarrett, Chief Operating Officer; Bob Goeltz, Chief Financial Officer; and Kartik Krishnan, Chief Medical Officer.
I'd like to remind you that on the call, management will make forward-looking statements within the meaning of securities law's safe harbor provision. For example, statements about our future clinical development plans and data releases as well as any anticipated benefits of the transaction. All statements other than historical facts involve risks
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |